nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—CYP2B6—Tamoxifen—pancreatic cancer	0.0943	0.14	CbGbCtD
Epinastine—CYP2B6—Irinotecan—pancreatic cancer	0.0724	0.108	CbGbCtD
Epinastine—HRH2—gastric juice—pancreatic cancer	0.0517	0.458	CbGeAlD
Epinastine—ABCB1—Tamoxifen—pancreatic cancer	0.0484	0.0718	CbGbCtD
Epinastine—CYP2D6—Tamoxifen—pancreatic cancer	0.0456	0.0677	CbGbCtD
Epinastine—ABCB1—Gemcitabine—pancreatic cancer	0.0417	0.0619	CbGbCtD
Epinastine—ABCB1—Erlotinib—pancreatic cancer	0.0411	0.0611	CbGbCtD
Epinastine—CYP2B6—Doxorubicin—pancreatic cancer	0.0396	0.0588	CbGbCtD
Epinastine—CYP2D6—Erlotinib—pancreatic cancer	0.0387	0.0576	CbGbCtD
Epinastine—ABCB1—Irinotecan—pancreatic cancer	0.0371	0.0552	CbGbCtD
Epinastine—CYP3A4—Tamoxifen—pancreatic cancer	0.029	0.043	CbGbCtD
Epinastine—HTR7—enteric nervous system—pancreatic cancer	0.0279	0.247	CbGeAlD
Epinastine—ABCB1—Docetaxel—pancreatic cancer	0.0272	0.0404	CbGbCtD
Epinastine—ABCB1—Sunitinib—pancreatic cancer	0.0271	0.0402	CbGbCtD
Epinastine—CYP3A4—Erlotinib—pancreatic cancer	0.0246	0.0366	CbGbCtD
Epinastine—CYP3A4—Irinotecan—pancreatic cancer	0.0222	0.033	CbGbCtD
Epinastine—ABCB1—Doxorubicin—pancreatic cancer	0.0203	0.0301	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—pancreatic cancer	0.0191	0.0284	CbGbCtD
Epinastine—HTR2A—enteric nervous system—pancreatic cancer	0.0174	0.154	CbGeAlD
Epinastine—CYP3A4—Docetaxel—pancreatic cancer	0.0163	0.0242	CbGbCtD
Epinastine—CYP3A4—Sunitinib—pancreatic cancer	0.0162	0.0241	CbGbCtD
Epinastine—CYP3A4—Doxorubicin—pancreatic cancer	0.0122	0.0181	CbGbCtD
Epinastine—HRH2—digestive system—pancreatic cancer	0.00315	0.0279	CbGeAlD
Epinastine—Cough increased—Tamoxifen—pancreatic cancer	0.00285	0.0488	CcSEcCtD
Epinastine—Lacrimation increased—Sunitinib—pancreatic cancer	0.00243	0.0415	CcSEcCtD
Epinastine—Eye irritation—Fluorouracil—pancreatic cancer	0.00207	0.0353	CcSEcCtD
Epinastine—Cough increased—Irinotecan—pancreatic cancer	0.00201	0.0344	CcSEcCtD
Epinastine—Lacrimation increased—Irinotecan—pancreatic cancer	0.002	0.0342	CcSEcCtD
Epinastine—ADRA2A—islet of Langerhans—pancreatic cancer	0.00196	0.0173	CbGeAlD
Epinastine—Lacrimation increased—Fluorouracil—pancreatic cancer	0.00192	0.0327	CcSEcCtD
Epinastine—HTR7—digestive system—pancreatic cancer	0.0016	0.0142	CbGeAlD
Epinastine—Eye irritation—Docetaxel—pancreatic cancer	0.00149	0.0255	CcSEcCtD
Epinastine—Nasopharyngitis—Sunitinib—pancreatic cancer	0.00145	0.0248	CcSEcCtD
Epinastine—Lacrimation increased—Docetaxel—pancreatic cancer	0.00138	0.0236	CcSEcCtD
Epinastine—ADRA2A—pancreas—pancreatic cancer	0.00138	0.0122	CbGeAlD
Epinastine—Sinusitis—Tamoxifen—pancreatic cancer	0.00137	0.0234	CcSEcCtD
Epinastine—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.0013	0.0223	CcSEcCtD
Epinastine—Pharyngitis—Tamoxifen—pancreatic cancer	0.0013	0.0223	CcSEcCtD
Epinastine—CYP2B6—digestive system—pancreatic cancer	0.00123	0.0109	CbGeAlD
Epinastine—HRH1—digestive system—pancreatic cancer	0.0012	0.0106	CbGeAlD
Epinastine—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.00115	0.0196	CcSEcCtD
Epinastine—ABCB1—islet of Langerhans—pancreatic cancer	0.00109	0.00966	CbGeAlD
Epinastine—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.00107	0.0184	CcSEcCtD
Epinastine—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.00103	0.0176	CcSEcCtD
Epinastine—HTR2A—digestive system—pancreatic cancer	0.001	0.00885	CbGeAlD
Epinastine—Cough—Tamoxifen—pancreatic cancer	0.000996	0.017	CcSEcCtD
Epinastine—Cough—Erlotinib—pancreatic cancer	0.000986	0.0169	CcSEcCtD
Epinastine—Cough increased—Epirubicin—pancreatic cancer	0.000939	0.016	CcSEcCtD
Epinastine—Lacrimation increased—Epirubicin—pancreatic cancer	0.000932	0.0159	CcSEcCtD
Epinastine—Rhinitis—Irinotecan—pancreatic cancer	0.000928	0.0159	CcSEcCtD
Epinastine—Sinusitis—Fluorouracil—pancreatic cancer	0.000926	0.0158	CcSEcCtD
Epinastine—Infection—Tamoxifen—pancreatic cancer	0.000926	0.0158	CcSEcCtD
Epinastine—CYP3A4—digestive system—pancreatic cancer	0.000926	0.0082	CbGeAlD
Epinastine—Infection—Erlotinib—pancreatic cancer	0.000916	0.0157	CcSEcCtD
Epinastine—CYP2D6—digestive system—pancreatic cancer	0.000911	0.00807	CbGeAlD
Epinastine—Rhinitis—Gemcitabine—pancreatic cancer	0.000904	0.0155	CcSEcCtD
Epinastine—Pharyngitis—Gemcitabine—pancreatic cancer	0.000895	0.0153	CcSEcCtD
Epinastine—Rhinitis—Fluorouracil—pancreatic cancer	0.000889	0.0152	CcSEcCtD
Epinastine—Pharyngitis—Fluorouracil—pancreatic cancer	0.00088	0.015	CcSEcCtD
Epinastine—Cough increased—Doxorubicin—pancreatic cancer	0.000869	0.0148	CcSEcCtD
Epinastine—Lacrimation increased—Doxorubicin—pancreatic cancer	0.000863	0.0147	CcSEcCtD
Epinastine—Cough—Sunitinib—pancreatic cancer	0.000853	0.0146	CcSEcCtD
Epinastine—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000827	0.0141	CcSEcCtD
Epinastine—Infection—Sunitinib—pancreatic cancer	0.000793	0.0136	CcSEcCtD
Epinastine—ABCB1—pancreas—pancreatic cancer	0.000767	0.00679	CbGeAlD
Epinastine—Cough—Irinotecan—pancreatic cancer	0.000703	0.012	CcSEcCtD
Epinastine—Cough—Gemcitabine—pancreatic cancer	0.000685	0.0117	CcSEcCtD
Epinastine—Pruritus—Tamoxifen—pancreatic cancer	0.000659	0.0113	CcSEcCtD
Epinastine—ABCB1—digestive system—pancreatic cancer	0.000655	0.0058	CbGeAlD
Epinastine—Infection—Irinotecan—pancreatic cancer	0.000653	0.0112	CcSEcCtD
Epinastine—Pruritus—Erlotinib—pancreatic cancer	0.000652	0.0112	CcSEcCtD
Epinastine—Rhinitis—Docetaxel—pancreatic cancer	0.000641	0.011	CcSEcCtD
Epinastine—Infection—Gemcitabine—pancreatic cancer	0.000636	0.0109	CcSEcCtD
Epinastine—Pharyngitis—Docetaxel—pancreatic cancer	0.000635	0.0109	CcSEcCtD
Epinastine—Infection—Fluorouracil—pancreatic cancer	0.000626	0.0107	CcSEcCtD
Epinastine—Headache—Tamoxifen—pancreatic cancer	0.000584	0.00998	CcSEcCtD
Epinastine—Headache—Erlotinib—pancreatic cancer	0.000578	0.00988	CcSEcCtD
Epinastine—Pruritus—Sunitinib—pancreatic cancer	0.000565	0.00965	CcSEcCtD
Epinastine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000558	0.00954	CcSEcCtD
Epinastine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000516	0.00882	CcSEcCtD
Epinastine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000501	0.00857	CcSEcCtD
Epinastine—Headache—Sunitinib—pancreatic cancer	0.0005	0.00855	CcSEcCtD
Epinastine—Cough—Docetaxel—pancreatic cancer	0.000486	0.00831	CcSEcCtD
Epinastine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000464	0.00793	CcSEcCtD
Epinastine—Pruritus—Gemcitabine—pancreatic cancer	0.000453	0.00775	CcSEcCtD
Epinastine—Infection—Docetaxel—pancreatic cancer	0.000452	0.00772	CcSEcCtD
Epinastine—Sinusitis—Epirubicin—pancreatic cancer	0.000451	0.00771	CcSEcCtD
Epinastine—Pruritus—Fluorouracil—pancreatic cancer	0.000446	0.00762	CcSEcCtD
Epinastine—Rhinitis—Epirubicin—pancreatic cancer	0.000433	0.0074	CcSEcCtD
Epinastine—Pharyngitis—Epirubicin—pancreatic cancer	0.000428	0.00732	CcSEcCtD
Epinastine—Sinusitis—Doxorubicin—pancreatic cancer	0.000417	0.00713	CcSEcCtD
Epinastine—Headache—Irinotecan—pancreatic cancer	0.000412	0.00704	CcSEcCtD
Epinastine—Headache—Gemcitabine—pancreatic cancer	0.000401	0.00686	CcSEcCtD
Epinastine—Rhinitis—Doxorubicin—pancreatic cancer	0.0004	0.00684	CcSEcCtD
Epinastine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000396	0.00677	CcSEcCtD
Epinastine—Headache—Fluorouracil—pancreatic cancer	0.000395	0.00674	CcSEcCtD
Epinastine—Cough—Epirubicin—pancreatic cancer	0.000328	0.0056	CcSEcCtD
Epinastine—Pruritus—Docetaxel—pancreatic cancer	0.000322	0.0055	CcSEcCtD
Epinastine—Infection—Epirubicin—pancreatic cancer	0.000305	0.00521	CcSEcCtD
Epinastine—Cough—Doxorubicin—pancreatic cancer	0.000303	0.00519	CcSEcCtD
Epinastine—Headache—Docetaxel—pancreatic cancer	0.000285	0.00487	CcSEcCtD
Epinastine—Infection—Doxorubicin—pancreatic cancer	0.000282	0.00482	CcSEcCtD
Epinastine—Pruritus—Epirubicin—pancreatic cancer	0.000217	0.00371	CcSEcCtD
Epinastine—Pruritus—Doxorubicin—pancreatic cancer	0.000201	0.00343	CcSEcCtD
Epinastine—Headache—Epirubicin—pancreatic cancer	0.000192	0.00328	CcSEcCtD
Epinastine—Headache—Doxorubicin—pancreatic cancer	0.000178	0.00304	CcSEcCtD
Epinastine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	2e-05	0.000129	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CXCL8—pancreatic cancer	2e-05	0.000129	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CD44—pancreatic cancer	2e-05	0.000129	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	1.99e-05	0.000128	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—PIK3CA—pancreatic cancer	1.98e-05	0.000127	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	1.98e-05	0.000127	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.96e-05	0.000126	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—VEGFA—pancreatic cancer	1.96e-05	0.000126	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TP53—pancreatic cancer	1.94e-05	0.000125	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—STAT3—pancreatic cancer	1.94e-05	0.000125	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—APOE—pancreatic cancer	1.93e-05	0.000124	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—NRAS—pancreatic cancer	1.93e-05	0.000124	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PIK3CB—pancreatic cancer	1.92e-05	0.000123	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.92e-05	0.000123	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—STK11—pancreatic cancer	1.91e-05	0.000123	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TERT—pancreatic cancer	1.9e-05	0.000122	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TERT—pancreatic cancer	1.9e-05	0.000122	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.89e-05	0.000122	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	1.86e-05	0.00012	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—HRAS—pancreatic cancer	1.86e-05	0.00012	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCL8—pancreatic cancer	1.84e-05	0.000119	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—HRAS—pancreatic cancer	1.83e-05	0.000118	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	1.82e-05	0.000117	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.82e-05	0.000117	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	1.82e-05	0.000117	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	1.82e-05	0.000117	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOE—pancreatic cancer	1.81e-05	0.000117	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	1.81e-05	0.000117	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.81e-05	0.000116	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.8e-05	0.000116	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MYC—pancreatic cancer	1.8e-05	0.000116	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TGFB1—pancreatic cancer	1.79e-05	0.000115	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	1.78e-05	0.000115	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—AKT1—pancreatic cancer	1.78e-05	0.000115	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	1.78e-05	0.000114	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.78e-05	0.000114	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOE—pancreatic cancer	1.78e-05	0.000114	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOE—pancreatic cancer	1.77e-05	0.000114	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CASP3—pancreatic cancer	1.77e-05	0.000114	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—pancreatic cancer	1.76e-05	0.000113	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	1.74e-05	0.000112	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KDR—pancreatic cancer	1.74e-05	0.000112	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	1.74e-05	0.000112	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KDR—pancreatic cancer	1.74e-05	0.000112	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	1.73e-05	0.000111	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCND1—pancreatic cancer	1.72e-05	0.000111	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	1.7e-05	0.00011	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CTNNB1—pancreatic cancer	1.7e-05	0.000109	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.69e-05	0.000108	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PPARG—pancreatic cancer	1.68e-05	0.000108	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—pancreatic cancer	1.67e-05	0.000107	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—KRAS—pancreatic cancer	1.66e-05	0.000107	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PTEN—pancreatic cancer	1.66e-05	0.000107	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	1.66e-05	0.000107	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.66e-05	0.000107	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	1.65e-05	0.000106	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	1.65e-05	0.000106	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.64e-05	0.000106	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	1.64e-05	0.000106	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.64e-05	0.000105	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	1.64e-05	0.000105	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.64e-05	0.000105	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.62e-05	0.000104	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—AKT1—pancreatic cancer	1.62e-05	0.000104	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	1.62e-05	0.000104	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.61e-05	0.000103	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.6e-05	0.000103	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	1.6e-05	0.000103	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	1.6e-05	0.000103	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	1.6e-05	0.000103	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGF—pancreatic cancer	1.59e-05	0.000102	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.58e-05	0.000102	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGF—pancreatic cancer	1.58e-05	0.000102	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.58e-05	0.000102	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.57e-05	0.000101	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.57e-05	0.000101	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.55e-05	9.98e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.55e-05	9.96e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—SRC—pancreatic cancer	1.54e-05	9.89e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.53e-05	9.87e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—PIK3CA—pancreatic cancer	1.53e-05	9.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.51e-05	9.69e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—VEGFA—pancreatic cancer	1.5e-05	9.64e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.49e-05	9.6e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—pancreatic cancer	1.48e-05	9.54e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NRAS—pancreatic cancer	1.48e-05	9.52e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—pancreatic cancer	1.48e-05	9.5e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	1.46e-05	9.4e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.46e-05	9.39e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.46e-05	9.39e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	1.46e-05	9.38e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.44e-05	9.28e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	1.44e-05	9.25e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.43e-05	9.2e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HRAS—pancreatic cancer	1.41e-05	9.09e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.41e-05	9.07e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	1.41e-05	9.05e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.4e-05	8.98e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.39e-05	8.96e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.38e-05	8.88e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	1.38e-05	8.88e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—pancreatic cancer	1.38e-05	8.87e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	1.38e-05	8.86e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFB1—pancreatic cancer	1.38e-05	8.85e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.37e-05	8.8e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	1.35e-05	8.69e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—pancreatic cancer	1.35e-05	8.67e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.34e-05	8.6e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOE—pancreatic cancer	1.34e-05	8.6e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.33e-05	8.55e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.32e-05	8.52e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.31e-05	8.4e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.28e-05	8.25e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KRAS—pancreatic cancer	1.27e-05	8.19e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.27e-05	8.17e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.27e-05	8.16e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.27e-05	8.14e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.26e-05	8.1e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.26e-05	8.08e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	1.25e-05	8.06e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.25e-05	8.06e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKT1—pancreatic cancer	1.25e-05	8.03e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	1.24e-05	7.99e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.24e-05	7.99e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.23e-05	7.9e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	1.23e-05	7.89e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.21e-05	7.76e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.2e-05	7.74e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	1.18e-05	7.6e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	1.18e-05	7.58e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.18e-05	7.57e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	1.17e-05	7.55e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	1.17e-05	7.53e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	1.17e-05	7.53e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.16e-05	7.49e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.16e-05	7.44e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.16e-05	7.43e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.15e-05	7.42e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.15e-05	7.39e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.14e-05	7.34e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	1.14e-05	7.32e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.14e-05	7.31e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—pancreatic cancer	1.13e-05	7.28e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	1.13e-05	7.27e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	1.13e-05	7.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.12e-05	7.19e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.12e-05	7.19e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.11e-05	7.12e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	1.1e-05	7.08e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	1.1e-05	7.06e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.1e-05	7.06e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.09e-05	7.01e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	1.09e-05	6.99e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTEN—pancreatic cancer	1.08e-05	6.97e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	1.08e-05	6.96e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.08e-05	6.93e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.07e-05	6.91e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	1.07e-05	6.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.07e-05	6.87e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.07e-05	6.86e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.07e-05	6.86e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	1.06e-05	6.83e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	6.82e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1.06e-05	6.82e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.05e-05	6.73e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.04e-05	6.69e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.04e-05	6.68e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	1.04e-05	6.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	1.03e-05	6.65e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.03e-05	6.61e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.01e-05	6.52e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.01e-05	6.52e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1e-05	6.44e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1e-05	6.43e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	9.91e-06	6.38e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	9.85e-06	6.33e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SRC—pancreatic cancer	9.83e-06	6.32e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	9.72e-06	6.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	9.66e-06	6.21e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	9.64e-06	6.2e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	9.59e-06	6.17e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	9.57e-06	6.16e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	9.56e-06	6.15e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	9.5e-06	6.11e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	9.48e-06	6.1e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	9.47e-06	6.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	9.45e-06	6.08e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	9.42e-06	6.06e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	9.39e-06	6.04e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	9.3e-06	5.98e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	9.28e-06	5.97e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	9.25e-06	5.95e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—pancreatic cancer	9.16e-06	5.89e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	8.96e-06	5.76e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	8.82e-06	5.68e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—pancreatic cancer	8.81e-06	5.66e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	8.8e-06	5.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	8.78e-06	5.65e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	8.73e-06	5.61e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	8.71e-06	5.6e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	8.64e-06	5.56e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	8.64e-06	5.56e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	8.63e-06	5.55e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	8.63e-06	5.55e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	8.62e-06	5.54e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	8.62e-06	5.54e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	8.61e-06	5.54e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	8.45e-06	5.44e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOE—pancreatic cancer	8.24e-06	5.3e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	8.15e-06	5.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	8.15e-06	5.24e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	8.14e-06	5.23e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	8.03e-06	5.16e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	8.01e-06	5.15e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTEN—pancreatic cancer	7.99e-06	5.14e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	7.98e-06	5.14e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	7.85e-06	5.05e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	7.64e-06	4.92e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.53e-06	4.84e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	7.49e-06	4.82e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	7.47e-06	4.81e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	7.43e-06	4.78e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	7.42e-06	4.77e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	7.33e-06	4.72e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	7.25e-06	4.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—pancreatic cancer	7.23e-06	4.65e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARG—pancreatic cancer	7.17e-06	4.62e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	7.1e-06	4.56e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	6.93e-06	4.46e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	6.92e-06	4.45e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	6.82e-06	4.38e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	6.79e-06	4.37e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AKT1—pancreatic cancer	6.66e-06	4.28e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	6.59e-06	4.24e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	6.54e-06	4.2e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	6.31e-06	4.06e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AKT1—pancreatic cancer	6.24e-06	4.02e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	6.12e-06	3.94e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	6.11e-06	3.93e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	5.99e-06	3.85e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.7e-06	3.66e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.64e-06	3.63e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	5.64e-06	3.63e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	5.57e-06	3.58e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	5.31e-06	3.42e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.92e-06	3.17e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AKT1—pancreatic cancer	4.6e-06	2.96e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.34e-06	2.79e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.47e-06	2.23e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.84e-06	1.82e-05	CbGpPWpGaD
